Dabang

Dabang is an emerging biotechnology company focused on the development of novel therapeutic solutions within the life sciences sector. The company primarily engages in the research and development of small molecule drugs and peptide-based therapeutics targeting complex diseases such as cancer and metabolic disorders. Dabang aims to leverage its proprietary discovery platforms to identify high-affinity targets and optimize lead compounds for clinical progression. While currently in the pre-clinical stage, the company is actively building a pipeline of candidates designed to address significant unmet medical needs. Dabang's business model emphasizes strategic collaborations and internal innovation to drive its therapeutic programs toward regulatory approval.